Market revenue in 2023 | USD 364.2 million |
Market revenue in 2030 | USD 478.6 million |
Growth rate | 4% (CAGR from 2023 to 2030) |
Largest segment | Peripheral stents |
Fastest growing segment | Plaque Modification Devices |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | PTA Balloons, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Peripheral Accessories, Inferior Vena Cava Filters, Hemodynamic Flow Alteration Devices, Peripheral Stents |
Key market players worldwide | Abbott Laboratories, Edwards Lifesciences Corp, Medtronic PLC, St. Jude Medical, Teleflex Inc, Philips, Boston Scientific Corp, Cook Group, Covidien, AngioScore |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to peripheral vascular devices market will help companies and investors design strategic landscapes.
Peripheral stents was the largest segment with a revenue share of 36.33% in 2024. Horizon Databook has segmented the Middle East & Africa peripheral vascular devices market based on pta balloons, catheters, endovascular aneurysm repair stent grafts, plaque modification devices, peripheral accessories, inferior vena cava filters, hemodynamic flow alteration devices, peripheral stents covering the revenue growth of each sub-segment from 2018 to 2030.
The Middle East and Africa (MEA) peripheral vascular devices market is experiencing unique regional dynamics that are impacting the market growth in near future. Notably, the rising prevalence of cardiovascular diseases in the region is a pivotal factor propelling the demand for peripheral vascular devices.
For instance, as per the report published by World Heart Federation 2023, in 2019, the North Africa and Middle East region exhibited the second-highest mortality rate due to cardiovascular diseases among both men and women. Specifically, the rates were 376.7 deaths per 100,000 people for men and 339.8 deaths per 100,000 people for women. The adoption of advanced technologies, specifically drug-eluting stents and bio resorbable stents, is significantly growing.
These technological advancements aim to enhance patient outcomes and mitigate the risk of adverse events, consequently boosting the demand for such devices in the MEA region. Furthermore, growing investments in healthcare infrastructure, marked by the establishment of new hospitals and clinics, are anticipated to fuel the demand for peripheral vascular devices. As an increasing number of patients seek treatment for cardiovascular diseases, the market is expected to grow.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa peripheral vascular devices market, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa peripheral vascular devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account